Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells are increased with age and elevated in donors with a history of cancer; an age-related effect has never been shown in humans. As we age, the composition of our peripheral leukocytes changes dramatically. Many of these alterations contribute to the general immune dysfunction that burdens the elderly, which in turn, contributes to increased susceptibility to disease. MDSCs represent a heterogeneous population of immunosuppressive leukocytes that are elevated in the peripheral blood of cancer patients. Given the relation between cancer incidence and age, this study examined the frequency of peripheral blood CD33(+)HLA-DR(−) MDSCs across three cohorts: healthy adults (19–59 years old), community-dwelling seniors (61–76 years old), and frail elderly (67–99 years old). This analysis is the first to demonstrate that MDSCs and specifically the CD11b(+)CD15(+) MDSC subset are increased with age. Proinflammatory cytokines that are required for the differentiation of MDSCs (e.g., TNF-α, IL-6, and IL-1β) were similarly found to be increased in the serum of the frail elderly. Furthermore, the proportion of MDSCs and the CD11b(+)CD15(+) subset were found to be elevated significantly in elderly donors with a history of cancer. This age-related elevation in the frequency of MDSCs may contribute to the increased cancer incidence that occurs with age. Further investigation into the functional consequences of elevated MDSCs will provide valuable insight into the progression of age-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is elevated with age and coincides with increases in both circulating immunosuppressive myeloid cells and cancer incidence26.”
From Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“sive, myeloid lineage cells in the peripheral blood [4].”
BackgroundDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215 · cited 1×
“been found to be associated with clinical scores, such as tumor stage, burden, and metastasis [10, 15].”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863 · cited 1×
“[19]).”
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862 · cited 8×
“MDSCs (CD33 HLA-DR ) and the CD11b CD15 MDSC subset were found to be increased significantly in seniors (0.29 0.03 and 0.17 0.03, respectively) and the frail elderly (0.40 0.03 and 0.29 0.02, respectively) as compared with healthy adults (0.22 0.03 and 0.11 0.03, respectively; Fig.”
BackgroundInfluentialLechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582 · cited 2×
“Furthermore, serum IL-6 has been shown to be correlated with MDSC frequency in patients with gastrointestinal cancer [20], and as mentioned above, proinflammatory cytokines are able to induce the differentiation of MDSCs in vitro [5, 8, 21].”
BackgroundRockwood, K., Song, X., & Mitnitski, A. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101271 · Cited by 573
Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W., Maisa, A., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00851.x · Cited by 547
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Inflammaging: disturbed interplay between autophagy and inflammasomes
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2012) · Aging · doi:10.18632/aging.100444 · Cited by 453
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398 · cited 1×
“categories [6, 7].”
Research works printed but not linked: 1
- U.S. Census Bureau (2001) The 65 Years and Older Population: 2000. Census 2000 Brief. U.S. Census Bureau, Washington, DC
Cited by
Items 201–235 of 235
Rink, L., & Weßels, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00072-0 · Cited by 4
Collier‐Bain, H. D., Emery, A., Brown, F. F., Causer, A. J., Oliver, R., Eddy, R., Leach, S., Graby, J., Augustine, D. X., Moore, S. E., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100865 · Cited by 3
“This panel of antibodies was also used to identify cells with a myeloid-derived suppressor cell (MDSC)-like phenotype (HLA-DR (cid:0) CD33 + ) (Verschoor et al., 2013; Gorgun et al., 2013).”
MethodAge‐Related Changes in Myeloid Cells and Their Impact on Subcutaneous Melanoma Growth in Mice
Landreth, K. M., Thomas, D. D., Nohoesu, R., Basnet, A., Damron, F. H., Garland‐Kledzik, M., Sen-Kilic, E., & Liu, T. W. B. (2025) · Aging and Cancer · doi:10.1002/aac2.70006 · Cited by 2
Tuosto, L., Gelibter, A. J., Strigari, L., Asquino, A., Siringo, M., Pace, A., Valentino, F., Capozzi, D., Bianchini, S., Bellati, F., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07719-9 · Cited by 1
“Similarly, immunosuppressive cells, such as Tregs and MDSCs, increased in percentage with age [13, 23–25].”
Immunosenescence and Cancer: Cellular Aging Programs That Reshape Antitumor Immunity
Oh, S.-H., Kim, Y. W., Kim, S. H., & Chang, S.-Y. (2026) · Immune Network · doi:10.4110/in.2026.26.e15 · Cited by 2
“Immunosenescence drives the accumulation and functional reinforcement of MDSCs. Increased numbers of MDSCs have been observed in the blood of healthy older adults (86), and significantly higher MDSC ratio have been observed in older adults individuals with a history of cancer (87).”
Myeloid-Derived Suppressive Cells in Ageing and Age-Related Diseases
Bueno, V., & Pawelec, G. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_4 · Cited by 1
Immunesenescence and Compromised Removal of Senescent Cells: Implications for Health in Old Age
Hazeldine, J., & Lord, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_3 · Cited by 1
Role of Regulatory Subsets During Aging
Wardowska, A., & Trzonkowski, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_18 · Cited by 1
In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
Kwack, K. H., Zhang, L., & Kirkwood, K. L. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.04.007 · Cited by 1
Wakita, H., Lü, Y., Li, X., Kobayashi, T., Hachiya, T., Ide, H., & Horie, S. (2024) · Cancers · doi:10.3390/cancers16071386 · Cited by 2
“Additionally, MDSCs serve as markers of immunosenescence, with their levels increasing with age [10–12].”
BackgroundOstrand‐Rosenberg, S. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104374 · Cited by 2
Breast Cancer and Immunosenescence
Provinciali, M., Pierpaoli, E., Malavolta, M., Donnini, A., Smorlesi, A., & Gatti, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_56-1 · Cited by 1
Effects of Ageing on Adaptive Immune Responses
Henson, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-43365-3_2 · Cited by 1
“Immune function is also controlled by regulatory T and B cells and myeloid-derived suppressor cells (MDSCs), with emerging data suggesting that the functional competence of these regulatory cells is altered during ageing (Fig.”
BackgroundInfluentialMyeloid-Derived Suppressor Cells (MDSCs) in Aged Mice: Focus on Inflammation
Pistoresi-Palencia, M. C., Harman, M. F., & Castell, S. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_95-1
Rodríguez, R., & Johanna, I. (2021)
Colleoni, G. W. B., & Bueno, V. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_8
Healthy Longevity and Immune System: A Brief Introduction
Laya, A., & Bueno, V. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_1
Role of Regulatory Subsets During Aging
Wardowska, A., & Trzonkowski, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_18-1
Frailty Research: The Present and the Future
Puts, M. T. E., Greystoke, A., & Mohile, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-89162-6_16
Cell biology and carcinogenesis in older people
Fülöp, T., Anisimov, V. N., Rodier, F., & Extermann, M. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0090 · Cited by 1
Myeloid-Derived Suppressor Cells (MDSCs) in Aged Mice: Focus on Inflammation
Pistoresi-Palencia, M. C., Harman, M. F., & Castell, S. D. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_95
Progress in understanding of relationship between inflammation and tumors
Chi, Z.-C. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i1.23
Can interventions targeting MDSCs improve the outcome of vaccination in vulnerable populations?
Perfilyeva, Y. V., Aquino, A. D., Borodin, M. A., Kali, A., Abdolla, N., Ostapchuk, Y. O., Tleulieva, R., Perfilyeva, A. V., Jainakbayev, N. T., Sharipov, K. O., et al. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2443423
Causal effects of immune cell populations on biological aging: a Mendelian randomization study
Fu, J., Wu, W. L., & Shen, S. (2025) · Biogerontology · doi:10.1007/s10522-025-10354-4
“These observations correspond with previous findings that CD33-positive myeloid-derived suppressor cells, particularly Blood CD33( +)HLA-DR(-) cells, accumulate with advancing age and cancer presence (Verschoor et al. 2013).”
Schrijver, I. T., Karakike, E., Théroude, C., Baumgärtner, P., Harari, A., Giamarellos-Bourboulis, E. J., Calandra, T., & Roger, T. (2022) · Figshare · doi:10.6084/m9.figshare.19158997
Shin, E.-Y., Jeong, S., Lee, J. E., Jeong, D. S., Han, D. K., Hong, S.-H., & Lee, D. R. (2024) · Figshare · doi:10.6084/m9.figshare.25333991
Schrijver, I. T., Karakike, E., Théroude, C., Baumgärtner, P., Harari, A., Giamarellos-Bourboulis, E. J., Calandra, T., & Roger, T. (2022) · Figshare · doi:10.6084/m9.figshare.19158994
Cheng, X., Chi, L., Lin, T., Liang, F., Pei, Z., Sun, J., & Teng, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611200
IL-6 and Immunosenescence in the Current Research on Immunotherapy for Elderly Lung Cancer Patients
李, 思. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162593
Research progress on the mechanism and intervention strategies of immunosenescence
Zhong-Yu, H. U., Chan-Chan, X. I. A. O., Yu-Dai, X. U., & Chen, G. (2026) · Shengming kexue · doi:10.3724/cbls.2026102
Niu, X., Nur, Z., Xie, W., Sun, Y., Wang, L. F., & Zheng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1781004 · Cited by 2
“In older adults and elderly cancer patients, increased circulating CD33 + HLA-DR-MDSCs have been reported, suggesting that aging-associated myeloid skewing may reinforce systemic and tumor-localized immune suppression (44).”
Placido, D. D., Ciaramella, A., Riccomi, A., Trombetta, C. M., Dorrucci, M., Farchi, F., Giuseppetti, R., Marchi, S., Sanarico, N., Pezzotti, P., et al. (2026) · Vaccines · doi:10.3390/vaccines14080680
“An increase in MDSCs during aging was also observed in humans, with many review studies suggesting an increase in MDSCs with age [12,16–18] and limited papers showing such an increase [19,20].”
Repair and regeneration across the lifespan: an ontogenetic perspective
Barrera-saldaña, H. A., Fernández-Garza, L. E., Guillen-Silva, F., Fajardo‐Ramírez, Ó. R., Pavlovich, R. I., Gómez-Gallardo, F. V., Rodríguez-Fuentes, D. E., Avila-Villalobos, A. Y., Barrera‐Barrera, S. A., & Somoza, R. A. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1888854 · Cited by 1
“Aged myeloid cells are characterized by elevated secretion of proinflammatory cytokines such as TNF-α and IL-6, contributing to a chronic low-grade inflammatory state termed “senoinflammation” (Hearps et al., 2012; Verschoor et al., 2013).”
IL-1-mediated cancer-adapted hematopoiesis in aging and clonal hematopoiesis
Caiado, F., Gonullu, N. G., & Manz, M. G. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102055 · Cited by 1
Chen, X., Liang, Z., Chen, X., Qian, O., Chen, Q., Zhu, L., Li, S., & Chen, K. (2026) · Cancer Medicine · doi:10.1002/cam4.72367
Metadata
- Authors
- Verschoor, C. P., Johnstone, J., Millar, J., Dorrington, M. G., Habibagahi, M., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- Shiraz University of Medical Sciences (IR)
- Corresponding author
- Bowdish, Dawn M E
- ORCID
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-01
- Volume
- 93
- Issue
- 4
- Pages
- 633-637
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- PMC
- PMC3701116
- OpenAlex
- W2095746947
- Cited by
- 235
- References
- 39
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 18 · 2023: 12 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 19 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 8
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Leukocyte Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- myeloid-derived suppressor cells, aging, frail elderly, cancer history, immunosenescence, immunosuppression, inflammatory cytokines, TNF-α, interleukin-6, IL-1β
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Cell Differentiation, Female, Fucosyltransferases, HLA-DR Antigens, Humans, Male, Middle Aged, Neoplasms, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Immunophenotyping, Lewis X Antigen, Myeloid Cells, CD11b Antigen, Interleukin-1beta, Sialic Acid Binding Ig-like Lectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.